Health Tech Capitol | Exact Sciences to buy California-based Genomic Health for $2.8 billion
16813
post-template-default,single,single-post,postid-16813,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Exact Sciences to buy California-based Genomic Health for $2.8 billion

29 Jul Exact Sciences to buy California-based Genomic Health for $2.8 billion

Posted at 14:25h in Uncategorized by
0 Likes

Madison-based cancer diagnostics company Exact Sciences Corp. said Monday it plans to acquire Redwood City, California-based Genomic Health in a $2.8 billion cash-and-stock deal.

Exact Sciences produces Cologuard, a noninvasive, at-home screening test that detects the presence of colon cancer in stool samples.

Genomic Health develops Oncotype IQ, a portfolio of genomic tests and services that check for various cancers, including breast and prostate.

Read more at BizTimes Milwaukee

No Comments

Sorry, the comment form is closed at this time.